arrow
S

Stephen Gottschalk

St Jude Children's Research Hospital
H指数:77
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Democratizing reliable knowledge-seeking with MyGPT: a privacy-first, open-source retrieval-augmented generation platform

通过MyGPT实现可靠知识获取的民主化:一个注重隐私、开源的检索增强生成平台

2026-10-240
OAAI
Sustained improvement in sickle cell cardiomyopathy after haematopoietic stem cell transplantation is superior to that with disease‐modifying therapy

镰状细胞心肌病在造血干细胞移植后持续改善优于疾病修饰疗法

2026-10-180
PRE
Targeting Regnase-1 in B7-H3-CAR T cells reprograms the tumor microenvironment and enhances antitumor efficacy for osteosarcoma

靶向B7-H3-CAR T细胞中的Regnase-1重编程肿瘤微环境并增强对骨肉瘤的抗肿瘤功效

2026-09-010
PRE
BACH2 regulates T cell lineage state to enhance CAR T cell function

BACH2调节T细胞谱系状态以增强CAR T细胞功能

2026-01-160
PRE
Increased capacity for expansion, not persistence, improves preclinical B7-H3 targeted CAR T cell therapy against aggressive Group 3 medulloblastomas

扩增能力而非持久性增强,可改善针对侵袭性Group 3髓母细胞瘤的B7-H3靶向CAR T细胞疗法的前临床效果

2025-11-010
OAAI
CELL-FREE DNA ANALYSIS OF CSF SAMPLES ENABLES ASSESSMENT OF TREATMENT RESPONSE AND TRACKING OF CAR T-CELLS POST-LOCOREGIONAL DELIVERY IN PEDIATRIC BRAIN TUMOR PATIENTS

脑脊液样本的无细胞DNA分析能够评估治疗反应,并追踪在儿科脑肿瘤患者中局部区域给药后的CAR T细胞。

2025-11-010
OAAI
Locoregional B7-H3 CAR-T cells for relapsed/refractory CNS tumors: preliminary clinical experience of the Loc3CAR trial

局部区域B7-H3 CAR-T细胞治疗复发/难治性中枢神经系统肿瘤:Loc3CAR试验的初步临床经验

2025-11-010
OAAI
Tumor inflammation-associated neurotoxicities for patients treated with intracranial B7-H3-CAR T cells on a phase I clinical trial

I期临床试验中接受颅内B7-H3-CAR T细胞治疗的患者的肿瘤炎症相关神经毒性

2025-11-010
OAAI